Medicines News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.07.14	The Medicines Company erhält Erneuerung der Zulassung für Angiox® (Bivalirudin) von der Europäischen Arzneimittel-Agentur und der Europäischen Kommission (Businesswire)
22.05.14	AKTUELLE DATEN ZU ANGIOX (BIVALIRUDIN) BEI PATIENTEN MIT HERZINFARKT AUF DEM EUROPCR VORGESTELLT UND ZEITGLEICH IM EUROPEAN HEART JOURNAL VERÖFFENTLICHT (Businesswire)
22.05.14	Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal (Businesswire)
23.04.14	Medicines Co. Agrees To Buy Tenaxis Medical - Quick Facts (RTTNews)
03.04.14	Medicines Co. Says FDA Accepts BLA For Fibrocaps - Quick Facts (RTTNews)
27.02.14	Medicines Co.'s MAA On Oritavancin Accepted In EU - Quick Facts (RTTNews)
19.02.14	Medicines Co. Q4 Profit Plunges (RTTNews)
14.02.14	DRRX Feels Pain, Bitter Pill For MDCO, RTRX Soars To New High, TRGT On Watch (RTTNews)
23.12.13	The Medicines Co. Says EMA Accepts Marketing Application For Cangrelor (RTTNews)
06.12.13	Boston Scientific & The Medicines Co. Announce U.S. Co-Promotion Deal (RTTNews)
04.12.13	Medicines Company Acquires Rempex Pharma - Quick Facts (RTTNews)
09.10.13	Critical Alerts For Groupon, ServiceNow, Trulia, Medicines, and Hanwha Solarone Released By InvestorsObserver (PR Newswire)
09.10.13	Drug Approvals, Data Presentations, Clinical Trials, New Appointments, and Corporate Events - Research Report on Johnson & Johnson, Novo Nordisk, Isis, Keryx, and The Medicines Company (PR Newswire)
09.10.13	Medicines Co. Enrolls First Patient In Phase III Trial Testing Angiomax (RTTNews)
17.09.13	Clinical Trial Updates, Appointments, FDA Acknowledgments and Qualifications - Research Report on Novartis, Endo, The Medicines Company, United Therapeutics, and Forest (PR Newswire)
03.09.13	Medicines Company Reports Pooled Analysis Of Cangrelor Phase III Trials (RTTNews)
30.08.13	Under AAAResearchReports.com Microscope: Life Technologies Corp., Opko Health Inc., Medicines Co., and DaVita Inc. (PR Newswire)
30.08.13	Under AAAResearchReports.com Microscope: Life Technologies Corp., Opko Health Inc., Medicines Co., and DaVita Inc. (PR Newswire)
14.08.13	Medicines Co. Prices Stock Offering (RTTNews)
13.08.13	Medicines Co. Launches Public Offering Of Up To 5.5 Mln Shares (RTTNews)
06.08.13	HNSN Jumps 22%, MDCO Reaches FINISH Line, SNY's Shot At Superbug Vaccine (RTTNews)
06.08.13	Medicines Co. Completes ProFibrix Acquisition (RTTNews)
29.07.13	Seeking Growth Opportunities through Understanding Market Trends, Strengthened R&D, and Global Expansion - Research Report on WellPoint, Thermo Fisher, Varian, Medicines Co., and Forest Laboratories (PR Newswire)
25.07.13	Today's Research: Life Technologies, Opko Health, Medicines, and DaVita (PR Newswire)
01.12.09	The Medicines Company erhält europäische Zulassung für Angiox® (Bivalirudin) zur Anwendung bei Herzinfarktpatienten, die sich einer Notoperation am Herzen unterziehen müssen (Businesswire)
23.10.09	The Medicines Company gibt positive Empfehlung des CHMP für Angiox® (Bivalirudin) bei Herzinfarktpatienten, die sich einem Notfalleingriff unterziehen, bekannt (Businesswire)
15.01.09	Hugin-News: The Medicines Company (GlobeNewswire)
22.10.08	The Medicines Company Reports Third Quarter 2008 Financial Results (Businesswire)
05.08.08	THE MEDICINES COMPANY ERWIRBT CU-2010 UND CURACYTE DISCOVERY GMBH (Businesswire)
05.08.08	Curacyte verkauft ihre Tochter Curacyte Discovery GmbH an The Medicines Company (Businesswire)
17.06.08	The Medicines Company beruft Glyn R. Parkin zum Senior Vice President, International Operations (Businesswire)
07.01.08	James Ferguson, MD Joins The Medicines Company as Vice President, Global Medical, Surgical and Critical Care (Businesswire)
25.10.07	Angiomax(R) / Angiox(R) (Bivalirudin): deutlich bessere Ergebnisse in der Behandlung von Herzinfarkten (Businesswire)
24.10.07	Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients (Businesswire)
23.10.07	Cleviprex(TM) (Clevidipine Butyrate) Rapidly Reduced Blood Pressure and Maintained Control in Study of Patients with Acute Hypertension (Businesswire)
19.04.06	The Medicines Company Reports First Quarter 2006 Financial Results (Businesswire)
12.03.06	Angiomax(R) (bivalirudin) Monotherapy Superior to Heparins Plus GP IIb/IIIa Combination for Net Clinical Outcome in ACUITY Trial (Businesswire)
15.02.06	The Medicines Company Reports Fourth Quarter and Full Year 2005 Financial Results (Businesswire)
05.04.05	The Medicines Company Appoints Elizabeth Wyatt to Board of Directors (Businesswire)
28.03.05	The Medicines Company Voluntarily Suspends Enrollment In Clevelox--TM- (Businesswire)
17.03.05	European Society of Cardiology Guidelines Recommend Bivalirudin -Angio (Businesswire)
23.02.05	The Medicines Company Reports Fourth Quarter and Year 2004 Financial R (Businesswire)
16.02.05	The Medicines Company Fourth Quarter and Full Year 2004 Financial Resu (Businesswire)
05.01.05	The Medicines Company Scheduled to Present at JPMorgan Healthcare Conf (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

25.11.19		Novartis-Aktie leicht im Plus, Medicines-Aktie springt an: Novartis wohl mit Medicines einig über Milliarden-Kauf
19.11.19		Medicines Co-Aktie +20%: Novartis angeblich an Medicines Co. interessiert

25.11.19

Novartis-Aktie leicht im Plus, Medicines-Aktie springt an: Novartis wohl mit Medicines einig über Milliarden-Kauf

19.11.19

Medicines Co-Aktie +20%: Novartis angeblich an Medicines Co. interessiert

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Medicines Co.

Aktien Top/Flop

Medicines Peer Group Nachrichten

Meistgelesene Nachrichten